Stay updated on Cusatuzumab Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.

Latest updates to the Cusatuzumab Combo in AML: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history shows recruitment is closed (no longer looking for participants) and the record revision was updated to v3.6.0, replacing the prior v3.5.5 label.SummaryDifference0.2%

- Check15 days agoChange DetectedThe page history now reflects a newer revision label in the footer, updating from v3.5.4 to v3.5.5 to indicate the latest page metadata.SummaryDifference0.1%

- Check36 days agoChange DetectedThe record history now shows a new revision entry (v3.5.4) and removes the previous revision (v3.5.3), indicating the study’s history has been updated to reflect a newer audit or adjustment to the record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a site software update without changing the underlying study listing or its displayed details.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Cusatuzumab Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.